Over the past four years, IESE’s Barcelona Technology Transfer Group (BTTG)  has worked with 24 early stage spin-outs across a range of technology and industrial applications.

The BTTG is an initiative launched at IESE in 2016, aimed at bringing its MBA talent into closer contact with scientists, doctors and researchers and accelerate the launch of deep-science-backed startups.

Sequentia Biotech, was one of  those companies selected by IESE to work alongside with their students, and as a result our CEO, Walter Sanseverino was invited to share his experience on the program.

The program is proof that business and science can coexist successfully, if the conditions are right and the mutual respect is there.